Home Data Calendar Blog

MRNA


Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Weighted Average Number Of Diluted Shares Outstanding 412.00419.00426.00NA434.00431.00430.00NA395.00381.00353.00NANANANANANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic 390.00396.00402.00NA404.00402.00400.00NA395.00381.00353.00NANANANANANANANANANANANA
Earnings Per Share Basic 2.675.559.0912.068.276.933.05-0.70-0.59-0.31-0.35NANANANANANANANANANANANA
Earnings Per Share Diluted 2.535.248.5811.297.706.462.84-0.70-0.59-0.31-0.35NANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Revenue From Contract With Customer Excluding Assessed Tax 3364.004749.006066.007211.004969.004354.001937.00570.75157.9166.358.3914.0517.0513.0816.0235.4241.7628.8529.0491.9042.4741.1230.33
Revenues 3364.004749.006066.007211.004969.004354.001937.00570.75157.9166.358.3914.0517.0513.0816.0235.4241.7628.8529.0491.9042.4741.1230.33
Cost Of Goods And Services Sold 1100.001381.001017.00952.00722.00750.00193.00NANANANANANANANANANANANANANANANA
Costs And Expenses 2198.002302.001839.001801.001411.001292.00671.00846.54392.00189.00139.00NANANANANANANANANANANANA
Research And Development Expense 820.00710.00554.00648.00521.00421.00401.00758.86344.49151.86115.14117.52119.72128.50130.57150.43109.05104.4890.12NANANANA
General And Administrative Expense 278.00211.00268.00201.00168.00121.0077.0078.9948.5436.6224.1125.6328.1928.5227.2838.0218.5221.3916.32NANANANA
Operating Income Loss 1166.002447.004227.005410.003558.003062.001266.00-275.04-235.12-122.13-130.86-130.56-130.86-143.94-141.83-153.03-85.82-97.02-77.40-41.83-67.87-94.19-65.46
Allocated Share Based Compensation Expense 70.0050.0044.0037.0040.0035.0030.0025.4823.2123.9220.4120.3320.8021.5018.5031.6414.7214.3511.85NANANANA
Income Tax Expense Benefit 174.00277.00572.00542.00219.00283.0039.001.470.860.150.07-0.17-0.18-0.32-0.020.170.000.160.00NANANANA
Net Income Loss 1043.002197.003657.004868.003333.002780.001221.00-272.49-233.64-116.71-124.23-123.12-123.19-135.05-132.66-141.43-80.33-90.60-72.38NANANANA
Comprehensive Income Net Of Tax 932.002141.003497.004813.003348.002795.001219.00-274.26-237.11-102.33-132.16-124.14-123.11-132.90-130.75-141.82-79.24-89.46-74.37NANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Assets 26056.0026043.0027609.0024669.0020923.0016153.0012694.007336.754650.873486.012067.541589.421590.901685.281806.211962.15NANANA1084.49NANANA
Liabilities 8064.008058.0010534.0010524.0010799.009449.008856.004775.381891.08539.12426.67414.61339.09346.73360.17431.91NANANA459.19NANANA
Liabilities And Stockholders Equity 26056.0026043.0027609.0024669.0020923.0016153.0012694.007336.754650.873486.012067.541589.421590.901685.281806.211962.15NANANA1084.49NANANA
Stockholders Equity 17992.0017985.0017075.0014145.0010124.006704.003838.002561.382759.802946.891640.871174.811251.811338.551446.031530.24-757.13-688.77-613.71-551.37NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Assets Current 14297.0013563.0016350.0016071.0013425.0010969.0011703.006297.883577.212796.741249.941128.801094.471097.421140.831563.01NANANA783.22NANANA
Cash And Cash Equivalents At Carrying Value 3027.002873.005048.006848.005550.005603.005442.002623.851505.581761.63391.72235.88173.71151.62502.93658.36167.06140.6290.48134.86NANANA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3041.002885.005060.006860.005561.005614.005453.002635.931517.671773.45403.54247.70185.53163.45514.76670.49179.42152.98102.51147.61NANANA
Accounts Receivable Net Current 2695.002691.003173.003175.003142.002020.003210.001390.56190.5033.365.625.032.803.505.6511.69NANANA11.88NANANA
Inventory Net 2077.001921.001942.001441.00965.00643.00494.0046.53NANANANANANANANANANANANANANANA
Other Assets Current 85.0076.0036.0055.0043.0038.00NA21.00NANANANANANANANANANANANANANANA
Prepaid Expense And Other Assets Current 1177.001054.001120.00728.00412.00316.00264.00252.15109.3845.3423.9019.4026.6822.4925.2928.40NANANA12.83NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Other Assets Noncurrent 38.0075.0082.0034.004.002.001.001.882.051.571.741.932.092.562.442.64NANANA4.59NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Liabilities Current 6807.006812.009238.009128.009957.008840.008441.004388.811473.56161.65134.58143.12147.84161.99159.16222.80NANANA191.46NANANA
Accounts Payable Current 330.00181.00199.00302.0087.0077.008.0018.3620.5218.8211.037.0911.7429.6138.5131.21NANANA20.73NANANA
Other Accrued Liabilities Current 130.00102.00116.00119.0088.0039.00NA25.00NANANANANANANANANANANANANANANA
Taxes Payable Current 66.00349.001592.00876.00565.00377.00NANANANANANANANANANANANANANANANANA
Accrued Liabilities Current 1856.001780.001608.001472.001076.00848.00753.00469.59208.8389.2055.0267.6560.0844.5942.1879.07NANANA72.72NANANA
Other Liabilities Current 553.00409.00240.00225.00252.00613.00149.0033.669.708.389.695.065.834.394.513.46NANANA1.28NANANA
Contract With Customer Liability Current 4002.004093.005599.006253.007977.007302.007531.003867.191234.5145.2458.8463.3170.1983.4073.96109.06NANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Other Liabilities Noncurrent 81.00113.0091.0076.001.001.002.001.852.181.221.250.140.160.190.210.26NANANA1.53NANANA
Operating Lease Liability Noncurrent 79.0087.0095.00106.00105.00105.0096.0097.4298.9599.64108.9293.67NANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Stockholders Equity 17992.0017985.0017075.0014145.0010124.006704.003838.002561.382759.802946.891640.871174.811251.811338.551446.031530.24-757.13-688.77-613.71-551.37NANANA
Additional Paid In Capital 1488.002413.003644.004211.005003.004931.004860.004801.854726.014675.993267.652669.432618.492582.132556.712538.16NANANA71.68NANANA
Retained Earnings Accumulated Deficit 16855.0015812.0013615.009958.005090.001757.00-1023.00-2243.52-1971.03-1737.40-1620.68-1500.00-1369.55-1246.35-1111.30-1006.63NANANA-621.89NANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -351.00-240.00-184.00-24.0031.0016.001.003.004.788.26-6.131.802.832.740.59-1.32NANANA-1.16NANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 70.0050.0044.0037.0040.0035.0030.0025.4823.2123.9220.4120.3320.8021.5018.5031.6414.7214.3511.85NANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Operating Activities 252.00304.002763.003310.003276.004063.002971.001264.29892.75-23.88-106.19-95.77-107.05-112.22-143.93-91.02-80.21-48.25-111.39NANANANA
Net Cash Provided By Used In Investing Activities 945.00-1152.00-3921.00-1138.00-3327.00-3878.00-180.00-190.13-1178.2612.48-316.02130.35113.37-246.90-11.766.79116.08-11.64-483.70NANANANA
Net Cash Provided By Used In Financing Activities -1041.00-1327.00-642.00NANA-24.0026.0044.1129.731381.31578.0527.5915.777.81-0.05575.91-9.43110.36550.00NANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Operating Activities 252.00304.002763.003310.003276.004063.002971.001264.29892.75-23.88-106.19-95.77-107.05-112.22-143.93-91.02-80.21-48.25-111.39NANANANA
Net Income Loss 1043.002197.003657.004868.003333.002780.001221.00-272.49-233.64-116.71-124.23-123.12-123.19-135.05-132.66-141.43-80.33-90.60-72.38NANANANA
Depreciation Depletion And Amortization 113.0076.0079.0078.0070.0069.0015.007.718.507.607.458.907.307.507.307.396.505.905.15NANANANA
Increase Decrease In Accounts Receivable 4.00-483.00-1.0033.001122.00-1190.001819.001200.06157.1427.410.582.23-0.70-2.15-6.041.84-1.553.39-3.88NANANANA
Increase Decrease In Inventories 156.00-21.00501.00476.00322.00148.00448.00NANANANANANANANANANANANANANANANA
Increase Decrease In Accounts Payable 145.00-21.00-35.00178.00-18.0059.00-15.00-1.762.169.142.33-4.78-17.71-3.201.7314.302.06-2.811.47NANANANA
Deferred Income Tax Expense Benefit -97.00-230.00-146.00-207.00-17.00-22.00-50.00NANANANANANANANANANANANANANANANA
Share Based Compensation 70.0050.0044.0037.0040.0035.0030.0025.4823.2123.9220.4120.3320.8021.5018.5031.6414.7214.3511.85NANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Investing Activities 945.00-1152.00-3921.00-1138.00-3327.00-3878.00-180.00-190.13-1178.2612.48-316.02130.35113.37-246.90-11.766.79116.08-11.64-483.70NANANANA
Payments To Acquire Property Plant And Equipment 89.0087.00132.00120.0099.0030.0035.0023.3019.2918.636.226.666.7110.597.5913.6426.1434.0831.91NANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Net Cash Provided By Used In Financing Activities -1041.00-1327.00-642.00NANA-24.0026.0044.1129.731381.31578.0527.5915.777.81-0.05575.91-9.43110.36550.00NANANANA
Payments For Repurchase Of Common Stock 1006.001298.00623.00NANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31
Revenues 3364.004749.006066.007211.004969.004354.001937.00570.75157.9166.358.3914.0517.0513.0816.0235.4241.7628.8529.0491.9042.4741.1230.33
Biomedical Advanced Research And Development Authority, Grant 141.00179.00122.00259.00128.00134.00192.00338.52143.3237.053.003.101.141.881.502.202.001.601.00NANANANA
Other Grant Revenue, Grant 3.004.004.003.0012.005.002.002.852.380.861.000.392.571.18NANANANANANANANANA
Collaboration Arrangement 100.0035.0015.0014.0019.0018.0010.0029.5012.2228.443.1910.059.619.8413.3019.9916.9319.7420.11NANANANA
Product Sales 3120.004531.005925.006935.004810.004197.001733.00NANANANANANANANANANANANANANANANA
Grant 144.00183.00126.00262.00140.00139.00194.00341.37145.6937.913.933.503.713.051.912.605.093.021.58NANANANA
Product Sales, 1045.001390.002076.003806.001688.001056.00284.00NANANANANANANANANANANANANANANANA
Product Sales,US 985.001450.00945.00745.001197.002093.001358.00NANANANANANANANANANANANANANANANA
Product Sales, Rest Of The World 1090.001691.002904.00NA1925.001048.0091.00NANANANANANANANANANANANANANANANA
Revenue From Contract With Customer Excluding Assessed Tax 3364.004749.006066.007211.004969.004354.001937.00570.75157.9166.358.3914.0517.0513.0816.0235.4241.7628.8529.0491.9042.4741.1230.33
Astra Zeneca, Collaboration Arrangement Including Arrangements With Affiliate 76.004.00NA0.003.004.00NA15.420.0516.001.000.513.72NANANANANANANANANANA
Merck, Collaboration Arrangement Including Arrangements With Affiliate 20.005.0010.0012.007.004.00NA8.026.7211.001.008.159.11NANANANANANANANANANA
Other Collaborative Parties, Collaboration Arrangement Including Arrangements With Affiliate 0.001.001.00NA4.001.001.00NANANANANANANANANANANANANANANANA
Vertex, Collaboration Arrangement Including Arrangements With Affiliate 4.0025.004.003.005.009.009.005.815.452.002.001.890.50NANANANANANANANANANA
Collaboration Arrangement Including Arrangements With Affiliate 100.0035.0015.0014.0019.0018.0010.0029.5012.2229.004.0010.5513.34NANANANANANANANANANA

Plots across concepts


IncomeStatement
Comprehensive Income Net Of Tax
Expenses
Other Nonoperating Income Expense
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Derivative Assets
Current Assets
Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
Liabilities
Derivative Liabilities
Current Liabilities
Operating Lease Liability Current
Stockholders Equity
Accumulated Other Comprehensive Income Loss Net Of Tax
CashFlow
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInOperatingActivities
Increase Decrease In Accounts Receivable
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
NetCashProvidedByUsedInFinancingActivities
Net Cash Provided By Used In Financing Activities
Shares
Common Stock Shares Issued
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
InventoryNet
Inventory Finished Goods Net Of Reserves

Line plots across dimensions of each concept


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName, us-gaap:ProductOrService
(None, 'mrna:CollaborationArrangementIncludingArrangementsWithAffiliate')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Counterparty Name, us-gaap: Product Or Service
us-gaap:Revenues
us-gaap:MajorCustomers, us-gaap:ProductOrService
(None, 'us-gaap:Grant')
Revenuesus-gaap: Major Customers, us-gaap: Product Or Service
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:StatementGeographical
('mrna:ProductSales', None)
Revenuesus-gaap: Product Or Service, us-gaap: Statement Geographical
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
(None,)
Allocated Share Based Compensation Expenseus-gaap: Award Type
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel
(None, 'us-gaap:FairValueInputsLevel2')
Available For Sale Securities Debt Securitiesus-gaap: Balance Sheet Location, us-gaap: Fair Value By Fair Value Hierarchy Level
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FinancialInstrument
('mrna:CurrentMarketableSecurities', 'us-gaap:FairValueInputsLevel2', None)
Available For Sale Securities Debt Securitiesus-gaap: Balance Sheet Location, us-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel2', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueMeasurementsRecurring', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel2', 'us-gaap:FairValueMeasurementsRecurring', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:Revenues
us-gaap:MajorCustomers, us-gaap:ProductOrService
(None, 'us-gaap:Grant')
Revenuesus-gaap: Major Customers, us-gaap: Product Or Service
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:StatementGeographical
('mrna:ProductSales', None)
Revenuesus-gaap: Product Or Service, us-gaap: Statement Geographical
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName, us-gaap:ProductOrService
(None, 'mrna:CollaborationArrangementIncludingArrangementsWithAffiliate')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Counterparty Name, us-gaap: Product Or Service